ElectroCore (id:5917 ECOR)
9.92 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 7:03:03 PM)
Exchange closed, opens in 14 hours 26 minutes
About ElectroCore
Market Capitalization 70.53M
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
| Headquarters (address) |
200 Forge Way Rockaway 07866 NJ United States |
| Phone | 973 290 0097 |
| Website | https://www.electrocore.com |
| Employees | 68 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | ECOR |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 5.02 - 14.20 |
| Market Capitalization | 70.53M |
| P/E trailing | -2.91 |
| P/E forward | -19.89 |
| Price/Sale | 3.31 |
| Price/Book | 8.82 |
| Beta | 0.562 |
| EPS | -2.05 |
| EPS United States (ID:6, base:3395) | 24.30 |